A

Affymax Inc
OTC:AFFY

Watchlist Manager
Affymax Inc
OTC:AFFY
Watchlist
Price: 0.001 USD Market Closed
Market Cap: $37.5k

Affymax Inc
Investor Relations

Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Mark G. Thompson
CFO & Secretary
No Bio Available
Mr. Jonathan M. Couchman CFA
CEO, President & Director
No Bio Available
Dr. Tracy J. Dunn Ph.D., J.D.
Vice President of Intellectual Property & Legal Affairs
No Bio Available

Contacts

Address
NEW YORK
New York City
630 5th Ave Ste 2260
Contacts
+16508128700.0
www.affymax.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett